EUVIMEDEUVIMED entdecken
Open Access

TOX-induced lnc-SUMF2-8 compromises antitumor function and anti-PD-1 response of CD8+ T cells via lysosome-dependent degradation of TCF-1

Pan Jiang, Dongming Chen, Jialin Chen, Junbin Wu, Yumin Zhong, Sijing Huang, Xiaoxin Mu, Xiaojie Lu, Xiaochen Wang

Molecular Therapy · 2025

DOI: 10.1016/j.ymthe.2025.09.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2025. Verfasst von Pan Jiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center of Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China; Clinical Nutrition Depart…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Lysosomes, Programmed Cell Death 1 Receptor, Hepatocyte Nuclear Factor 1-alpha. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The reduction of TCF-1 during CD8+ T cell exhaustion leads to attenuated antitumor activity and diminished responsiveness to immune checkpoint inhibitors. However, how TCF-1 is downregulated remains unclear. Here, we showed that during CD8+ T cell exhaustion, lnc-SUMF2-8, induced by transcription factor TOX, can bind to cytosolic TCF-1 and direct it to the lysosome for degradation. The reduction of TCF-1 promotes Texprog differentiation into Texint/eff and further drives functional Tex cells into a fully dysfunctional Texterm state. We demonstrated that TCF-1 reduction during T cell exhaustion is initiated by lnc-SUMF2-8-dependent lysosomal degradation of TCF-1 protein, followed by transcriptional suppression of TCF7 mRNA. Deletion of lnc-SUMF2-8 blocks lysosomal TCF-1 degradation, which maintains stable TCF-1 levels in Tex cells, thereby expanding the anti-PD-1-responsive Texprog cells and enhances the persistence of functional CD8+ T cells. Our findings suggest that targeting lnc-SUMF2-8 could enhance the function of the antitumor CD8+ T cells and synergistically improve the efficacy of anti-PD-1 treatment and CAR-T cell therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesLysosomesProgrammed Cell Death 1 ReceptorHepatocyte Nuclear Factor 1-alphaRNA, Long NoncodingT Cell Transcription Factor 1NeoplasmsAnimalsMiceHumansCell Line, TumorProteolysisImmune Checkpoint Inhibitors

Stichwörter der Autor:innen

T cell exhaustionTCF-1anti-PD-1 responsehepatocellular carcinomalnc-SUMF2-8

Substanzen

Programmed Cell Death 1 ReceptorHepatocyte Nuclear Factor 1-alphaRNA, Long NoncodingT Cell Transcription Factor 1TCF7 protein, humanImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Center of Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China; Clinical Nutrition Department of Zhongshan Hospital, Fudan University, Shanghai 200000, China.
  • Center of Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
  • Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
  • Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China; Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor…
  • Center of Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China; Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzh…

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • Natural Science Foundation of Guangdong Province
  • Sun Yat-sen University

Zitieren

APA

Jiang, P., Chen, D., Chen, J., Wu, J., Zhong, Y., Huang, S., Mu, X., Lu, X., & Wang, X. (2025). TOX-induced lnc-SUMF2-8 compromises antitumor function and anti-PD-1 response of CD8+ T cells via lysosome-dependent degradation of TCF-1. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2025.09.006

Vancouver

Jiang P, Chen D, Chen J, Wu J, Zhong Y, Huang S, et al. TOX-induced lnc-SUMF2-8 compromises antitumor function and anti-PD-1 response of CD8+ T cells via lysosome-dependent degradation of TCF-1. Molecular Therapy. 2025. doi:10.1016/j.ymthe.2025.09.006

BibTeX
@article{Jiang2025,
  author = {Jiang, Pan and Chen, Dongming and Chen, Jialin and Wu, Junbin and Zhong, Yumin and Huang, Sijing and Mu, Xiaoxin and Lu, Xiaojie and Wang, Xiaochen},
  title = {TOX-induced lnc-SUMF2-8 compromises antitumor function and anti-PD-1 response of CD8+ T cells via lysosome-dependent degradation of TCF-1},
  journal = {Molecular Therapy},
  year = {2025},
  doi = {10.1016/j.ymthe.2025.09.006}
}
Kostenlos starten →